Healthcare Professional Check

This website is intended for diabetes healthcare professionals. Click one of the options below to access the content.

You are here

Convenience, Compliance and Overcoming Clinical Inertia for Diabetes Specialists

This course reviews the practical aspects of basal insulin–glucagon-like peptide-1 (GLP-1) receptor agonist combination therapy, and shows how fixed-dose combination therapies provide added convenience that may help overcome clinical inertia related to insulin initiation and intensification. Clinical data will be presented to demonstrate how the efficacy and safety of basal insulin–GLP-1 receptor agonist combination therapy surpasses that of the individual components. After completing the course, participants will be able to identify patients for whom treatment with basal insulin–GLP-1 receptor agonist combination therapy may be a viable option, and know how to best manage these patients.

Now available